AmyT

Crystal Meth Addiction

Last night my man and I watched an A&E Special Documentary on the “epidemic” of crystal meth use in rural America.  (Which we’d Tivo’ed; everything’s an “epidemic” these days, no?)  It was fascinating in the way that makes your skin crawl.  I mean, meth doesn’t seem to be the scariest of all drugs out there, but the sheer numbers of addicts (supposedly 1.4M in America) and the type of people getting into it are kind…

Read more »

Arthur Gets Cute with Diabetes, and SugarStats.com

Two unrelated juicy tips today:
1) Did you know that the popular Arthur cartoon series recently aired an episode featuring a pediatric pump patient?  The girl, named Corinne, discusses her condition, displays her Animas insulin pump, and even demonstrates LifeScan UltraSmart blood glucose monitoring — a mucho PR win for LifeScan, of course. But thanks for making diabetes “a little hip,” ay?  The episode, called “Desert Island Dish,” also features a segment on choosing healthy…

Read more »

Full Disclosure: Who’s Your Daddy?

OK, so I received a journalism award from a major pharmaceutical company whose practices we may all question at times.  Does accepting this award mean that I am somehow “in” with the Big Pharma crowd, receiving perks left and right?  Hell no.
Yesterday I received the following email from a long-time reader:
You’ve been honest, forthright, and sincere in your weblog to date.  I will continue to read it so long as you maintain the…

Read more »

Trouble in Reimbursement City

We’ve been asking the question, “How soon will insurance providers start covering continuous glucose monitoring (CGM) devices?”  But it seems the more accurate inquiry would be, “Why won’t insurance providers ‘reimburse’ for CGM devices any time soon?”
There are some serious barriers in the way, as I’ve experienced personally in the last few weeks, submitting multiple claims for my DexCom supplies — and receiving rejection after complicated rejection.  Each “Explanation of Benefits” form from Blue…

Read more »

Avandia DREAMs

So I’m sure you’ve all seen the headlines by now: “Drug helps head off Type 2 diabetes,” “Glaxo drug may prevent diabetes,” “Avandia a diabetes DREAM?,” and so on. 

                                                                                           What the flurry’s all about is the recent annoucement of results from the DREAM study (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) — the largest diabetes prevention study ever conducted, which shows convincing evidence that the insulin sensitizer drug rosiglitazone (Avandia) dramatically
reduces the chance…

Read more »